Study to Evaluate the Use of Direct Oral Anticoagulants in UK Clinical Practice For Patients With a First Stroke Attributable to Nonvalvular Atrial Fibrillation

NCT05262322 · clinicaltrials.gov ↗

COMPLETED

Status

234

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: Edoxaban
DRUG: Apixaban
DRUG: Rivaroxaban

Sponsor

Daiichi Sankyo UK Ltd, a Daiichi Sankyo Company